[根据2021年EAN/PNS指南更新的慢性炎症性脱叶林性多基基隆性神经病的诊断和治疗方法]
1Department of Neurology, Graduate School of Medicine, Chiba University.
Brain and nerve = Shinkei kenkyu no shinpo
|December 26, 2024
概括
慢性炎症性脱髓化多基原蛋白神经病变 (CIDP) 准则于2021年更新,分类变体并概述诊断标准. 治疗侧重于皮质类固醇和免疫球蛋白治疗典型的CIDP.
科学领域:
- 神经学 神经学
- 临床医学 临床医学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性炎症性脱髓化多基原蛋白神经病 (CIDP) 包含多种不同的临床亚型,典型的CIDP具有对称的近端和远端肌肉衰弱.
- 历史上的定义排除了诸如多焦点运动神经病变,抗MAG神经病变和自身免疫结节病变等疾病.
- 国际CIDP诊断和治疗指南最初于2005年发布,于2010年修订,并于2021年更新.
研究的目的:
- 审查2021年欧洲神经科学院/外围神经学会 (EAN/PNS) 关于CIDP诊断和治疗的指南.
- 为了澄清CIDP及其变体的不断变化的概念.
- 突出电诊断,神经成像和新型治疗方法的进步.
主要方法:
- 审查CIDP诊断和治疗的国际指南.
- 基于表型的CIDP变体的分类.
- 诊断标准的总结,包括表型,电生理学和排除标准.
- 推的第一线和维持疗法的概述.
主要成果:
- 2021年EAN/PNS指南代表了第二次修订,包括更新的疾病概念和诊断/治疗进展.
- CIDP变体与典型的CIDP一起被分类.
- 诊断依赖于典型的CIDP或变异的表型,脱髓化的电生理学证据和排除标准.
- 皮质类固醇和免疫球蛋白治疗是典型的CIDP的第一线治疗方法,免疫球蛋白被推用于维持治疗.
结论:
- 2021年指南为CIDP诊断和管理提供了一个全面的框架.
- 目前典型的CIDP的治疗策略包括皮质类固醇和免疫球蛋白治疗.
- 需要进一步的研究来解决关于不断发展的CIDP概念和未来治疗选择的尚未解决的问题.
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...


